REPLIGEN CORP Share Price
REPLIGEN CORP (RGEN) had Share Price of $288.99 per share as of 2021-09-30, per its 10-Q filed 2021-10-28.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2021-10-28
- 2021-09-30: Share Price $288.99.
- 2021-06-30: Share Price $199.62.
- 2021-03-31: Share Price $194.41.
- 2020-09-30: Share Price $147.54.
| Period end | Share Price |
|---|---|
| 2021-09-30 | $288.99 10-Q · filed 2021-10-28 |
| 2021-06-30 | $199.62 10-Q · filed 2021-07-27 |
| 2021-03-31 | $194.41 10-Q · filed 2021-05-04 |
| 2020-09-30 | $147.54 10-Q · filed 2020-11-05 |
| 2020-06-30 | $123.61 10-Q · filed 2020-07-30 |
| 2020-03-31 | $96.54 10-Q · filed 2020-05-06 |
| 2019-09-30 | $76.69 10-Q · filed 2019-10-31 |
| 2019-06-30 | $85.95 10-Q · filed 2019-08-01 |
| 2019-03-31 | $59.08 10-Q · filed 2019-05-09 |
| 2018-12-31 | $52.74 10-K · filed 2019-03-01 |
| 2018-09-30 | $55.46 10-Q · filed 2018-11-01 |
| 2018-06-30 | $47.04 10-Q · filed 2018-08-02 |
| 2018-03-31 | $36.18 10-Q · filed 2018-05-08 |
| 2017-12-31 | $36.28 10-K · filed 2018-02-22 |
| 2017-09-30 | $38.32 10-Q · filed 2017-11-09 |
| 2017-06-30 | $41.44 10-Q · filed 2017-08-03 |
| 2017-03-31 | $35.20 10-Q · filed 2017-05-04 |
| 2016-12-31 | $30.82 10-K · filed 2017-02-23 |
| 2016-09-30 | $30.19 10-Q · filed 2016-11-03 |
| 2016-06-30 | $27.36 10-Q · filed 2016-08-04 |
| 2016-03-31 | $26.82 10-Q · filed 2016-05-05 |
| 2015-12-31 | $28.29 10-K · filed 2016-02-25 |
| 2015-09-30 | $27.85 10-Q · filed 2015-11-05 |
| 2015-06-30 | $41.27 10-Q · filed 2015-08-06 |
| 2015-03-31 | $30.36 10-Q · filed 2015-05-08 |
| 2014-12-31 | $19.80 10-K · filed 2015-03-17 |
| 2014-09-30 | $19.91 10-Q · filed 2014-11-07 |
| 2014-06-30 | $22.79 10-Q · filed 2014-08-11 |
| 2014-03-31 | $12.86 10-Q · filed 2014-05-09 |
| 2013-12-31 | $13.64 10-K · filed 2014-03-14 |
| 2013-09-30 | $11.09 10-Q · filed 2013-11-08 |
| 2013-06-30 | $8.24 10-Q · filed 2013-08-07 |
| 2013-03-31 | $6.91 10-Q · filed 2013-05-07 |
| 2012-12-31 | $6.28 10-K · filed 2013-03-15 |
| 2012-09-30 | $5.96 10-Q · filed 2012-11-08 |
| 2012-06-30 | $4.30 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |